Novel fluorinated ring-fused chlorins as promising PDT agents against melanoma and esophagus cancer.

Investigation of novel 4,5,6,7-tetrahydropyrazolo[1,5-]pyridine-fused chlorins, derived from 5,10,15,20-tetrakis(pentafluorophenyl)porphyrin, as PDT agents against melanoma and esophagus cancer is disclosed. Diol and diester fluorinated ring-fused chlorins, including derivatives with 2-(2-hydroxyethoxy)ethanamino groups at the phenyl rings, were obtained a two-step methodology, combining SAr and [8π + 2π] cycloaddition reactions. The short-chain PEG groups at the -position of the phenyl rings together with the diol moiety at the fused pyrazole ring promote a red-shift of the Soret band, a decrease of the fluorescence quantum yield and an increase of the singlet oxygen formation quantum yield, improving the photophysical characteristics required to act as a photosensitizer. Introduction of these hydrophilic groups also improves the incorporation of the sensitizers by the cells reaching cellular uptake values of nearly 50% of the initial dose. The rational design led to a photosensitizer with impressive IC values, 13 and 27 nM against human melanoma and esophageal carcinoma cell lines, respectively.